1Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing tacrolimcks (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplanration 1997 ; 64: 436 -- 443.
2Shaw KT, Ho AM, Raghavan A, et al. Immunosurppressive durgs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. ProcNatl Acad Sci USA 1995 ; 92 : 11205 -- 11209.
7Sollinger HW., Deierboi MH, Belzer FO, et al. RS61443:a phase I clinical trial and pilot rescus study [ J ]. Transplantation, 1992, 53:428.
8Chan TM, Li FK, Tang CS, et al. Efficiency of mycophenolate motefil in patients with disease proliferative lupus nephritis[J]. N EnglMed, 2002, 343 : 1 156 - 1 162.
10Miller G, Zimmerman R, Rad hakrishnan K, et al. Use of mycophenolate mofetil in resist, at membranous nephropathy[J ]. Am J Kidney Dis, 2000, 36:250 - 256.
